Articles

Find an Article

Filter articles

Applied Filters

Showing 11 to 20 of 88 results

LSIPR 50 2018: Sung Yunmo

South Korea24-07-2018

Sung Yunmo was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Levelling the medicines playing field

India02-07-2018

Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition.

Protecting patients, and patents

Canada, Indonesia, Singapore04-06-2018

Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out.

Regulation and licensing: the CRISPR conundrum continues

China, EU, US04-06-2018

As innovation in the CRISPR field continues across the world, questions are being asked about the role of regulating such a powerful tool, while discussions around licensing the technology continue, as LSIPR reports.

Uncertain times for antibodies in India

India31-05-2018Archana Shanker and Nupur Maithani

In India, there are two core areas of the antibody patenting field that are unsettled and need correcting, as Archana Shanker and Nupur Maithani of Anand and Anand explain.

Patents and biodiversity: crossing the divide

India15-05-2018Vidisha Garg

The Indian Patent Office has attempted to bridge the divide between the laws on patents and biological diversity, but instead it created a maze of problems, says Vidisha Garg of Anand and Anand.

Clearing a way through the CRISPR patent jungle

Belgium, Denmark, International08-05-2018Timo Minssen, Esther van Zimmeren, Jakob Wested

There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.

Conference preview: ChinaBio Partnering Forum

China12-04-2018

The ChinaBio Partnering Forum, which will be held in Suzhou from April 25 to 26, is celebrating its tenth anniversary and is expected to attract pharma and biotech companies from around the world.

LSIPR 50 2017: Gyanendra Nath Singh and Krishnaswamy VijayRaghavan

India10-11-2017

Gyanendra Nath Singh and Krishnaswamy VijayRaghavan were selected in the LSIPR 50 2017 publication for​ ​their influence on the life sciences industry. They featured in the government and policy​ ​section, as LSIPR reports.

LSIPR 50 2017: Yasuhisa Shiozaki

Japan10-11-2017

Yasuhisa Shiozaki was selected in the LSIPR 50 2017 publication for​ ​his influence on the life sciences industry. He featured in the government and policy​ ​section, as LSIPR reports.

Showing 11 to 20 of 88 results

LSIPR